CN105981026A - 生物标志标识方法及用于其的装置和试剂盒 - Google Patents

生物标志标识方法及用于其的装置和试剂盒 Download PDF

Info

Publication number
CN105981026A
CN105981026A CN201580007568.9A CN201580007568A CN105981026A CN 105981026 A CN105981026 A CN 105981026A CN 201580007568 A CN201580007568 A CN 201580007568A CN 105981026 A CN105981026 A CN 105981026A
Authority
CN
China
Prior art keywords
immune system
biomarker
indicant
group
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201580007568.9A
Other languages
English (en)
Chinese (zh)
Inventor
理查德·布鲁斯·布兰登
里奥·查尔斯·麦克休
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunexpress Pty Ltd
Original Assignee
Immunexpress Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014900363A external-priority patent/AU2014900363A0/en
Application filed by Immunexpress Pty Ltd filed Critical Immunexpress Pty Ltd
Publication of CN105981026A publication Critical patent/CN105981026A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Artificial Intelligence (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Data Mining & Analysis (AREA)
CN201580007568.9A 2014-02-06 2015-02-06 生物标志标识方法及用于其的装置和试剂盒 Pending CN105981026A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2014900363A AU2014900363A0 (en) 2014-02-06 Biomarker Signature Method, and Apparatus and Kits Therefor
AU2014900363 2014-02-06
PCT/AU2015/050043 WO2015117204A1 (en) 2014-02-06 2015-02-06 Biomarker signature method, and apparatus and kits therefor

Publications (1)

Publication Number Publication Date
CN105981026A true CN105981026A (zh) 2016-09-28

Family

ID=53754326

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580007568.9A Pending CN105981026A (zh) 2014-02-06 2015-02-06 生物标志标识方法及用于其的装置和试剂盒

Country Status (8)

Country Link
US (4) US11047010B2 (https=)
EP (1) EP3103046B1 (https=)
JP (1) JP2017512304A (https=)
CN (1) CN105981026A (https=)
AU (1) AU2015213486B2 (https=)
CA (1) CA2930925A1 (https=)
DK (1) DK3103046T3 (https=)
WO (1) WO2015117204A1 (https=)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105506172A (zh) * 2016-03-01 2016-04-20 北京泱深生物信息技术有限公司 含检测gfod2的骨质疏松血液诊断试剂及其应用
CN106755343A (zh) * 2016-12-01 2017-05-31 北京致成生物医学科技有限公司 胰腺癌预后诊断分子标记物
CN106947808A (zh) * 2017-03-10 2017-07-14 北京赛尔得生物技术有限公司 Tmem104基因在制备治疗椎间盘退行性疾病药物中的应用
CN107133475A (zh) * 2017-05-10 2017-09-05 浙江省立同德医院 一种中药注射剂不良反应高危患者模式识别方法
CN108341862A (zh) * 2017-01-24 2018-07-31 上海交通大学医学院附属仁济医院 一种多肽及其应用
CN108753834A (zh) * 2018-05-28 2018-11-06 上海海洋大学 ddx27基因缺失斑马鱼突变体的制备方法
CN109762911A (zh) * 2019-02-21 2019-05-17 华中农业大学 Ptprj基因作为猪免疫相关性状的分子标记及其应用
CN110191960A (zh) * 2016-11-08 2019-08-30 克维拉公司 进行核酸稳定和分离的方法
CN110558279A (zh) * 2019-09-16 2019-12-13 南方科技大学 一种药物筛选模型、药物筛选方法及其应用
CN110567861A (zh) * 2019-09-09 2019-12-13 浙江普罗亭健康科技有限公司 基于质谱流式检测技术筛查具有免疫原性抗原肽的试剂盒及检测方法
CN110687285A (zh) * 2019-10-29 2020-01-14 安徽医科大学 诊断试剂盒及mak16在制备系统性红斑狼疮早期诊断试剂中的应用
CN110791523A (zh) * 2019-12-13 2020-02-14 南京农业大学 一种棉花抗旱相关基因GhRCHY1及其应用
CN111276248A (zh) * 2020-01-20 2020-06-12 苏州帕诺米克生物医药科技有限公司 状态确定系统和电子设备
CN111443065A (zh) * 2019-01-17 2020-07-24 四川大学华西医院 一种肺癌的筛查试剂盒
CN112409376A (zh) * 2019-08-20 2021-02-26 华东师范大学 一种基于dcaf15的蛋白降解靶向嵌合体及其制备方法和应用
CN112553322A (zh) * 2020-12-25 2021-03-26 深圳市人民医院 一种骨质疏松诊断标志物及其应用
CN114164277A (zh) * 2020-03-30 2022-03-11 中国医学科学院肿瘤医院 用于肺癌诊断的试剂盒、装置及方法
CN114487402A (zh) * 2020-11-12 2022-05-13 首都医科大学附属北京世纪坛医院 尿液非分泌核糖核酸酶蛋白及其多肽片段在妊娠糖尿病中的应用
CN119842884A (zh) * 2025-01-09 2025-04-18 湖北文理学院 Tm9sf1在制备用于监测脓毒症病程的试剂中的应用
CN120405150A (zh) * 2025-07-01 2025-08-01 南昌大学第一附属医院 Itga6在制备脓毒症诊断及病情监测试剂或试剂盒中的应用

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10190169B2 (en) 2013-06-20 2019-01-29 Immunexpress Pty Ltd Biomarker identification
US11047010B2 (en) 2014-02-06 2021-06-29 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits thereof
AU2016267392B2 (en) * 2015-05-28 2021-12-09 Immunexpress Pty Ltd Validating biomarker measurement
CN108513586A (zh) * 2015-09-30 2018-09-07 因姆内克斯普雷斯私人有限公司 病原体生物标志物及其用途
EP3371324B1 (en) * 2015-11-06 2021-08-18 ImmuneXpress Pty Ltd Viral biomarkers and uses therefor
CN106701900B (zh) * 2015-11-16 2020-03-20 上海市东方医院 长链非编码rna herc2p3基因及其在胃癌中的用途
CN105256063B (zh) * 2015-12-01 2019-03-01 北京泱深生物信息技术有限公司 肿瘤标志物dmbx1及其应用
AU2016377391B2 (en) 2015-12-24 2022-09-01 Immunexpress Pty Ltd Triage biomarkers and uses therefor
US20230187067A1 (en) * 2016-03-23 2023-06-15 Peach Intellihealth, Inc. Use of clinical parameters for the prediction of sirs
AU2017315328A1 (en) * 2016-08-24 2019-03-21 Immunexpress Pty Ltd Systemic inflammatory and pathogen biomarkers and uses therefor
GB201616557D0 (en) * 2016-09-29 2016-11-16 Secretary Of State For Health The Assay for distinguishing between sepsis and systemic inflammatory response syndrome
US11435370B2 (en) * 2017-01-16 2022-09-06 Shimadzu Corporation Data analying device and program for data analysis
WO2018140256A1 (en) * 2017-01-17 2018-08-02 Duke University Gene expression signatures useful to predict or diagnose sepsis and methods of using the same
EP3879535B1 (en) 2017-06-13 2024-12-11 BostonGene Corporation Systems and methods for identifying cancer treatments from normalized biomarker scores
WO2019095064A1 (en) * 2017-11-15 2019-05-23 UNIVERSITé LAVAL Use of srsf3 agents for the treatment and/or prevention of neurological conditions, cancer, bacterial infections or viral infections
CN108467890A (zh) * 2018-05-02 2018-08-31 首都医科大学附属北京天坛医院 Vat1基因及vat1基因的干扰物的应用和应用vat1基因的产品
WO2020096984A1 (en) * 2018-11-05 2020-05-14 Institute For Systems Biology Sepsis biomarker panels and methods of use
AU2019380342A1 (en) * 2018-11-15 2021-07-01 Ampel Biosolutions, Llc Machine learning disease prediction and treatment prioritization
WO2020132327A1 (en) * 2018-12-19 2020-06-25 The Trustees Of The University Of Pennsylvania Use of cd2/5/7 knock-out anti-cd2/5/7 chimeric antigen receptor t cells against t cell lymphomas and leukemias
US12288623B2 (en) 2019-03-19 2025-04-29 Optina Diagnostics, Inc. Method and system for identifying subjects who are potentially impacted by a medical condition
CA3178405A1 (en) 2020-05-14 2021-11-18 Katherine A. OWEN Methods and systems for machine learning analysis of single nucleotide polymorphisms in lupus
CA3211700A1 (en) * 2021-02-11 2022-08-18 Herbert A. Fritsche Kits and methods for detecting markers and determining the presence or risk of cancer
CN113125757B (zh) * 2021-04-22 2022-10-28 石河子大学 一种用于母猪早期妊娠诊断的蛋白生物标志物及其用于母猪早期妊娠检测的方法
WO2022226267A1 (en) * 2021-04-23 2022-10-27 Alnylam Pharmaceuticals, Inc. iRNA COMPOSITIONS AND METHODS FOR SILENCING CHITINASE 3-LIKE PROTEIN 1/YKL-40 (CHI3L1/YKL-40) PROTEIN
AU2022283025A1 (en) * 2021-05-25 2024-01-18 The University Of British Columbia Diagnostic for sepsis endotypes and/or severity
WO2023034111A1 (en) * 2021-08-30 2023-03-09 Inflammatix, Inc. A baseline gene expression-based prognostic for anti-tnf alpha therapy response in patients with inflammatory bowel disease
AU2022375208B2 (en) * 2021-10-29 2024-06-06 GenoDx Pty Ltd Biomarkers and uses therefor
CN114875144B (zh) * 2022-04-02 2026-04-17 及智(苏州)医学技术有限公司 用于评估肿瘤ibc疗法的疗效的生物标志物、系统、方法及试剂盒
WO2023224913A1 (en) * 2022-05-16 2023-11-23 Cz Biohub Sf, Llc Integrated host-microbe metagenomics of cell-free nucleic acid for sepsis diagnosis
EP4471784A1 (fr) * 2023-05-31 2024-12-04 Biomérieux Procede et systeme de typage probabiliste de souches microbiennes
EP4471785A1 (fr) * 2023-05-31 2024-12-04 Biomérieux Procede et systeme de typage probabiliste de souches microbiennes
WO2025257393A1 (en) * 2024-06-14 2025-12-18 Roche Diagnostics Gmbh Method and system for improving biomarker based disease assessments

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219760A1 (en) * 2001-09-05 2003-11-27 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
CN1829730A (zh) * 2002-11-12 2006-09-06 贝克顿迪金森公司 使用生物标记谱诊断脓毒或者sirs
WO2007060647A2 (en) * 2005-11-25 2007-05-31 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin A method for detecting or monitoring sepsis by analysing cytokine mrna expression levels
US20070154931A1 (en) * 2005-12-15 2007-07-05 Radich Jerald P Genes associate with progression and response in chronic myeloid leukemia and uses thereof
WO2009045443A2 (en) * 2007-10-02 2009-04-09 The University Of Rochester Methods and compositions related to synergistic responses to oncogenic mutations
US20090203534A1 (en) * 2005-10-21 2009-08-13 Hamid Hossain Expression profiles for predicting septic conditions
WO2010083252A2 (en) * 2009-01-14 2010-07-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Ratio based biomarkers and methods of use thereof
US20110312521A1 (en) * 2010-06-17 2011-12-22 Baylor Research Institute Genomic Transcriptional Analysis as a Tool for Identification of Pathogenic Diseases
US20120082659A1 (en) * 2007-10-02 2012-04-05 Hartmut Land Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
WO2012068642A1 (en) * 2010-11-26 2012-05-31 Immunexpress Pty Ltd Diagnostic and/or screening agents and uses therefor
CN105518153A (zh) * 2013-06-20 2016-04-20 因姆内克斯普雷斯私人有限公司 生物标志物鉴定

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980488A7 (fi) * 1998-03-04 1999-09-05 Arctic Partners Oy Ab Uusi diagnostinen menetelmä
US20070134261A1 (en) 2001-12-03 2007-06-14 Hancock Robert E Effectors of innate immunity
JP2004041121A (ja) * 2002-07-12 2004-02-12 Hitachi Ltd アレルギー解析方法及びシステム
US20040096917A1 (en) 2002-11-12 2004-05-20 Becton, Dickinson And Company Diagnosis of sepsis or SIRS using biomarker profiles
US20080070235A1 (en) 2003-04-02 2008-03-20 Sirs-Lab Gmbh Method for Recognizing Acute Generalized Inflammatory Conditions (Sirs), Sepsis, Sepsis-Like Conditions and Systemic Infections
EP1639090A4 (en) * 2003-06-09 2008-04-16 Univ Michigan COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER
JP2007518062A (ja) * 2003-09-29 2007-07-05 バイオサイト インコーポレイテッド 敗血症を診断する方法および診断するための組成物
DE102004009952B4 (de) 2004-03-01 2011-06-01 Sirs-Lab Gmbh Verfahren zur Erkennung von Sepsis
US9164104B2 (en) 2004-10-06 2015-10-20 The Brigham And Women's Hospital, Inc. Relevance of achieved levels of markers of systemic inflammation following treatment
CA2605143A1 (en) 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnosis of sepsis
EP1907858A4 (en) 2005-06-13 2009-04-08 Univ Michigan COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER
US20070255113A1 (en) 2006-05-01 2007-11-01 Grimes F R Methods and apparatus for identifying disease status using biomarkers
WO2008021115A2 (en) 2006-08-14 2008-02-21 The Brigham And Women's Hospital, Inc. Diagnostic tests using gene expression ratios
EP2185728A2 (en) * 2007-09-07 2010-05-19 Université Libre de Bruxelles Methods and tools for prognosis of cancer in er- patients
DE102008000715B9 (de) 2008-03-17 2013-01-17 Sirs-Lab Gmbh Verfahren zur in vitro Erfasssung und Unterscheidung von pathophysiologischen Zuständen
JP2009229340A (ja) * 2008-03-25 2009-10-08 Sysmex Corp 全身性炎症反応症候群の重症度に関する情報を生成する方法及び装置
AU2010270313B2 (en) 2009-07-10 2014-05-22 Transgene Sa Biomarker for selecting patients and related methods
US20110076685A1 (en) 2009-09-23 2011-03-31 Sirs-Lab Gmbh Method for in vitro detection and differentiation of pathophysiological conditions
EP2756118A4 (en) 2011-09-16 2015-09-16 Cepheid METHOD FOR DETECTING SEPSIS
US20150315643A1 (en) 2012-12-13 2015-11-05 Baylor Research Institute Blood transcriptional signatures of active pulmonary tuberculosis and sarcoidosis
US11047010B2 (en) 2014-02-06 2021-06-29 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits thereof

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219760A1 (en) * 2001-09-05 2003-11-27 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
CN1829730A (zh) * 2002-11-12 2006-09-06 贝克顿迪金森公司 使用生物标记谱诊断脓毒或者sirs
US20090203534A1 (en) * 2005-10-21 2009-08-13 Hamid Hossain Expression profiles for predicting septic conditions
WO2007060647A2 (en) * 2005-11-25 2007-05-31 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin A method for detecting or monitoring sepsis by analysing cytokine mrna expression levels
US20070154931A1 (en) * 2005-12-15 2007-07-05 Radich Jerald P Genes associate with progression and response in chronic myeloid leukemia and uses thereof
WO2009045443A2 (en) * 2007-10-02 2009-04-09 The University Of Rochester Methods and compositions related to synergistic responses to oncogenic mutations
US20120082659A1 (en) * 2007-10-02 2012-04-05 Hartmut Land Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
WO2010083252A2 (en) * 2009-01-14 2010-07-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Ratio based biomarkers and methods of use thereof
US20110312521A1 (en) * 2010-06-17 2011-12-22 Baylor Research Institute Genomic Transcriptional Analysis as a Tool for Identification of Pathogenic Diseases
WO2012068642A1 (en) * 2010-11-26 2012-05-31 Immunexpress Pty Ltd Diagnostic and/or screening agents and uses therefor
CN105518153A (zh) * 2013-06-20 2016-04-20 因姆内克斯普雷斯私人有限公司 生物标志物鉴定

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MARKOULATOS等: "Multiplex Polymerase Chain Reaction：A Practical Approach", 《JOURNAL OF CLINICAL LABORATORY ANALYSIS》 *
PANKLA等: "Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis", 《GENOME BIOLOGY》 *
PETERS等: "Real-time RT-PCR: considerations for efficient and sensitive assay design", 《JOURNALOF IMMUNOLOGICAL METHODS》 *

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105506172A (zh) * 2016-03-01 2016-04-20 北京泱深生物信息技术有限公司 含检测gfod2的骨质疏松血液诊断试剂及其应用
CN105506172B (zh) * 2016-03-01 2019-04-09 北京泱深生物信息技术有限公司 含检测gfod2的骨质疏松血液诊断试剂及其应用
CN110191960A (zh) * 2016-11-08 2019-08-30 克维拉公司 进行核酸稳定和分离的方法
CN106755343A (zh) * 2016-12-01 2017-05-31 北京致成生物医学科技有限公司 胰腺癌预后诊断分子标记物
CN108341862B (zh) * 2017-01-24 2021-04-02 上海交通大学医学院附属仁济医院 一种多肽及其应用
CN108341862A (zh) * 2017-01-24 2018-07-31 上海交通大学医学院附属仁济医院 一种多肽及其应用
CN106947808A (zh) * 2017-03-10 2017-07-14 北京赛尔得生物技术有限公司 Tmem104基因在制备治疗椎间盘退行性疾病药物中的应用
CN106947808B (zh) * 2017-03-10 2020-07-24 北京赛尔得生物技术有限公司 Tmem104基因在制备治疗椎间盘退行性疾病药物中的应用
CN107133475B (zh) * 2017-05-10 2020-09-29 浙江省立同德医院 一种中药注射剂不良反应高危患者模式识别方法
CN107133475A (zh) * 2017-05-10 2017-09-05 浙江省立同德医院 一种中药注射剂不良反应高危患者模式识别方法
CN108753834A (zh) * 2018-05-28 2018-11-06 上海海洋大学 ddx27基因缺失斑马鱼突变体的制备方法
CN111443065A (zh) * 2019-01-17 2020-07-24 四川大学华西医院 一种肺癌的筛查试剂盒
CN109762911A (zh) * 2019-02-21 2019-05-17 华中农业大学 Ptprj基因作为猪免疫相关性状的分子标记及其应用
CN109762911B (zh) * 2019-02-21 2020-12-01 华中农业大学 Ptprj基因作为猪免疫相关性状的分子标记及其应用
CN112409376A (zh) * 2019-08-20 2021-02-26 华东师范大学 一种基于dcaf15的蛋白降解靶向嵌合体及其制备方法和应用
CN110567861A (zh) * 2019-09-09 2019-12-13 浙江普罗亭健康科技有限公司 基于质谱流式检测技术筛查具有免疫原性抗原肽的试剂盒及检测方法
CN110567861B (zh) * 2019-09-09 2021-12-21 浙江普罗亭健康科技有限公司 基于质谱流式检测技术筛查具有免疫原性抗原肽的试剂盒及检测方法
CN110558279A (zh) * 2019-09-16 2019-12-13 南方科技大学 一种药物筛选模型、药物筛选方法及其应用
CN110558279B (zh) * 2019-09-16 2021-11-16 南方科技大学 一种药物筛选模型、药物筛选方法及其应用
CN110687285A (zh) * 2019-10-29 2020-01-14 安徽医科大学 诊断试剂盒及mak16在制备系统性红斑狼疮早期诊断试剂中的应用
CN110791523B (zh) * 2019-12-13 2022-05-10 南京农业大学 一种棉花抗旱相关基因GhRCHY1及其应用
CN110791523A (zh) * 2019-12-13 2020-02-14 南京农业大学 一种棉花抗旱相关基因GhRCHY1及其应用
CN111276248A (zh) * 2020-01-20 2020-06-12 苏州帕诺米克生物医药科技有限公司 状态确定系统和电子设备
CN111276248B (zh) * 2020-01-20 2023-09-12 苏州帕诺米克生物医药科技有限公司 状态确定系统和电子设备
CN114164277A (zh) * 2020-03-30 2022-03-11 中国医学科学院肿瘤医院 用于肺癌诊断的试剂盒、装置及方法
CN114164277B (zh) * 2020-03-30 2022-08-26 中国医学科学院肿瘤医院 外泌体arpc5、kyat3等在肺癌诊断中的应用
CN114487402A (zh) * 2020-11-12 2022-05-13 首都医科大学附属北京世纪坛医院 尿液非分泌核糖核酸酶蛋白及其多肽片段在妊娠糖尿病中的应用
CN112553322A (zh) * 2020-12-25 2021-03-26 深圳市人民医院 一种骨质疏松诊断标志物及其应用
CN112553322B (zh) * 2020-12-25 2022-07-05 深圳市人民医院 一种骨质疏松诊断标志物及其应用
CN119842884A (zh) * 2025-01-09 2025-04-18 湖北文理学院 Tm9sf1在制备用于监测脓毒症病程的试剂中的应用
CN119842884B (zh) * 2025-01-09 2025-09-19 湖北文理学院 Tm9sf1在制备用于监测脓毒症病程的试剂中的应用
CN120405150A (zh) * 2025-07-01 2025-08-01 南昌大学第一附属医院 Itga6在制备脓毒症诊断及病情监测试剂或试剂盒中的应用

Also Published As

Publication number Publication date
JP2017512304A (ja) 2017-05-18
AU2015213486A1 (en) 2016-06-02
EP3103046A4 (en) 2017-08-23
EP3103046B1 (en) 2020-03-25
CA2930925A1 (en) 2015-08-13
AU2015213486B2 (en) 2020-10-22
US20220325348A1 (en) 2022-10-13
US20150259746A1 (en) 2015-09-17
US11047010B2 (en) 2021-06-29
WO2015117204A1 (en) 2015-08-13
WO2015117204A9 (en) 2016-06-23
EP3103046A1 (en) 2016-12-14
AU2015213486A9 (en) 2016-07-07
US20170191129A1 (en) 2017-07-06
US20150218640A1 (en) 2015-08-06
DK3103046T3 (da) 2020-06-02
US10865447B2 (en) 2020-12-15

Similar Documents

Publication Publication Date Title
US20220325348A1 (en) Biomarker signature method, and apparatus and kits therefor
US20260015666A1 (en) Biomarker identification
JP7813140B2 (ja) 病原体検出のための配列決定データを使用するためのシステムおよび方法
US20200232046A1 (en) Genomic sequencing classifier
EP4247980A2 (en) Determination of cytotoxic gene signature and associated systems and methods for response prediction and treatment
US20240201186A1 (en) Triage biomarkers and use therefor
WO2012150276A1 (en) Blood-based gene expression signatures in lung cancer
US20250137066A1 (en) Compostions and methods for diagnosing lung cancers using gene expression profiles
US20150099643A1 (en) Blood-based gene expression signatures in lung cancer
WO2015117205A1 (en) Biomarker signature method, and apparatus and kits therefor
US20250263795A1 (en) Methods for classification of tissue samples as positive or negative for cancer
HK1228037A1 (en) Biomarker signature method, and apparatus and kits therefor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1228037

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160928

WD01 Invention patent application deemed withdrawn after publication